Status:
COMPLETED
Comparative Study of the Efficacy of TENS Versus Placebo in Isolated Primary Enuresis
Lead Sponsor:
Fondation Lenval
Conditions:
Enuresis, Nocturnal
Eligibility:
All Genders
5-17 years
Phase:
NA
Brief Summary
Nocturnal enuresis is a functional urinary disorder in children. It is intermittent urinary incontinence during sleep in children aged 5 years and older. It is said to be "primary" if the child has ne...
Detailed Description
Nocturnal enuresis is a functional urinary disorder in children. It is intermittent urinary incontinence during sleep in children aged 5 years and older. It is said to be "primary" if the child has ne...
Eligibility Criteria
Inclusion
- Children 5 to 17 years old
- Medium or severe isolated primary enuresis (more than 1 episode per week)
- Never treated or in failure of previous treatment (with treatment discontinuation for at least 1 month)
- Affiliation to a social security scheme
- Good understanding of the protocol
- Signature of informed consent by a parent or the legal representative of parental authority
Exclusion
- Other pathologies which can influence urination behavior (Daytime urinary disorders)
- Treatment in progress which can modify voiding behavior
- TENS treatment in progress for another pathology
Key Trial Info
Start Date :
January 13 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 14 2024
Estimated Enrollment :
54 Patients enrolled
Trial Details
Trial ID
NCT04413461
Start Date
January 13 2021
End Date
November 14 2024
Last Update
April 1 2025
Active Locations (4)
Enter a location and click search to find clinical trials sorted by distance.
1
CH de Cannes
Cannes, France
2
CH de GRASSE
Grasse, France
3
CHU de Nice
Nice, France
4
Hôpitaux Pédiatrique de Nice CHU Lenval
Nice, France